The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech/Roche
Research Funding - Roche
Updated survival and biomarker analyses of a randomized phase II study of atezolizumab vs docetaxel in 2L/3L NSCLC (POPLAR).
 
David A. Smith
Employment - US Oncology
Travel, Accommodations, Expenses - US Oncology
 
Johan F. Vansteenkiste
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst)
Research Funding - AstraZeneca (Inst)
 
Louis Fehrenbacher
Research Funding - Roche/Genentech (Inst)
 
Keunchil Park
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Hanmi; Kyowa Hakko Kirin; Lilly; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - Boehringer Ingelheim
Research Funding - AstraZeneca
 
Julien Mazieres
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly/ImClone; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech
Research Funding - Puma Biotechnology; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Achim Rittmeyer
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech
 
Angel Artal-Cortes
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche
 
Conrad R. Lewanski
Consulting or Advisory Role - Amgen; Celgene; Roche/Genentech
 
Fadi S. Braiteh
Employment - US Oncology
Honoraria - Ambry Genetics; Amgen; BIND Biosciences; bioTheranostics; Caris Life Sciences; Foundation Medicine; Incyte; Insys Therapeutics; Ipsen; Lilly; Merrimack; MolecularHealth; Novartis; Novocure; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Ambry Genetics; Amgen; BIND Biosciences; bioTheranostics; Caris Life Sciences; Foundation Medicine; Incyte; Insys Therapeutics; Ipsen; Lilly; Merrimack; MolecularHealth; Novartis; Novocure; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Genomic Health; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merrimack; Pfizer; Sanofi
Travel, Accommodations, Expenses - Ambry Genetics; Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Celgene; Foundation Medicine; Genomic Health; HERON; Incyte; Insys Therapeutics; Ipsen; Lilly; Merrimack; MolecularHealth; Novartis; Pfizer; Roche/Genentech
 
Jing Yi
Employment - Genentech; Genentech (I)
Stock and Other Ownership Interests - Genentech; Genentech (I)
 
Pei He
Employment - Amgen; Genentech
Stock and Other Ownership Interests - Allergan; Amgen; Gilead Sciences; Roche/Genentech
 
Wei Zou
No Relationships to Disclose
 
Marcin Kowanetz
Employment - Genentech
Stock and Other Ownership Interests - Genentech; Roche
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Genentech
 
Daniel Waterkamp
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Marcus Ballinger
Employment - Genentech
Stock and Other Ownership Interests - Exelixis; Roche; Sunesis Pharmaceuticals
 
Daniel S. Chen
Employment - Genentech
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Genentech/Roche (I)
 
Alan Sandler
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Alexander I. Spira
Honoraria - Novartis; Roche
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; MedImmune; Roche
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Roche